Pune, Jan. 17, 2023 (GLOBE NEWSWIRE) -- According to the "Solid Tumor Testing Market" research published by Maximize Market Research, the market is expected to grow from USD 32.48 billion in 2021 to USD 59.45 billion in 2029, at a CAGR of 7.85 percent during the forecast period from 2022 to 2029. Technological advances, the launch of different products, and major player strategies such as acquisition, partnership, and agreement serve as possible prospects for the global solid tumor testing market growth
Solid Tumor Testing Market Scope and Research Methodology
The research report involves the extensive usage of both primary and secondary data sources. The research process is the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industries and market risks, opportunities, market barriers, and challenges. In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global solid tumor testing market.
Get a Sample PDF Brochure:
https://www.maximizemarketresearch.com/request-sample/167421
Solid Tumor Testing Market Overview
Several diagnostic methods, including fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), polymerase chain reaction (PCR), and next-generation sequencing, are mostly used for solid tumor testing (NGS). The development of molecular diagnostic tools for the genomic evaluation of diverse solid tumors is the result of modern technologies having a substantial influence on solid tumor testing methodologies. The development of genetic analysis has also improved cancer patient decision-making processes for diagnosis, prognosis, monitoring, and therapy driving the market demand. One of the key factors driving the growth of the solid tumor testing market is the increase in the number of cancer patients. The increasing use of spatial methodologies in cancer research and diagnostics, as well as the development of cutting-edge technology for error reduction, are driving the market's growth.
Solid Tumor Testing Market Dynamics
The demand for diagnostic testing is high, and the pressure on public hospitals is growing as a result of the limited number of imaging modalities that are accessible. The number of private diagnostic centers is rising quickly across the world. The increased incidence of different types of metastatic cancer is expected to fuel the market growth during the forecast period. various malignant illnesses are becoming more commonplace very quickly. The market for solid tumor testing is likely to be driven by the increased need for testing due to lung, colorectal, breast, and liver malignancies. The two most common types of solid tumors are brain and neuroblastomas. Rhabdomyosarcoma and osteosarcoma are less common types of solid malignancies that require regular testing and are additionally expected to boost the growth of the solid tumor testing market during the forecast period.
Get a Sample PDF Brochure:
https://www.maximizemarketresearch.com/request-sample/167421
Solid Tumor Testing Market Regional Insights
The Noth American Solid Tumor Testing Market is expected to dominate the market during the forecast period. Growing development of new technologies for the treatment. The growing development of original therapeutic methods Modern research institutes and facilities are available in the region, along with advanced healthcare infrastructure and rising per capita income drive the market growth. solid tumor testing market makes use of technologies like next-generation sequencing, in-situ hybridization, immunohistochemistry, polymerase chain reaction, and others to meet the demands of a comprehensive approach to cancer therapy driving the market demand during the forecast period.
Asia Pacific market held the second largest market share in 2021. Increasing numbers of older adults, government initiatives, and growing healthcare expandechure drive the regional market.
| Market Size in 2021 | USD 32.48 Bn. |
| Market Size in 2029 | USD 59.45 Bn. |
| CAGR | 7.85% (2022-2029) |
| Forecast Period | 2022-2029 |
| Base Year | 2021 |
| Number of Pages | 213 |
| No. of Tables | 110 |
| No. of Charts and Figures | 112 |
| Segement Covered | Testing Application, End-User |
| Regional Scope | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Report Coverage | Market Share, Size & Forecast by Revenue | 2022−2029, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis. |
Download Free Sample Report at:
https://www.maximizemarketresearch.com/request-sample/167421
Solid Tumor Testing MarketKey Competitors:
- Abbott Laboratories
- Agilent Technologies
- 20/20 Gene Systems Inc.
- Thermo Fisher Scientific, Inc.
- Avant Diagnostics, Inc.
- Advanced Cell Diagnostics, Inc.
- Agena Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- Johnson & Johnson`
- Biocare Medical, LLC.
- ARUP Laboratories
- Caris Life Sciences.
- F. Hoffmann-La Roche Ltd
- Genomic Testing Cooperative
- Guardant Health
- HTG Molecular Diagnostics, Inc.
- Illumina, Inc.
- Invitae Corporation
- Invivoscribe, Inc.
- Laboratory Corporation of America Holdings
- NanoString
- NeoGenomics Laboratories
- Opko Health, Inc.
- QIAGEN
- Quest Diagnostics Incorporated.
- Thermo Fisher Scientific, Inc.
- VYANTbio.
- MedGenome Labs Private Ltd.
- Myraid Genetics, Inc.
- Thermo Fisher Scientific, Inc
Key questions answered in the Solid Tumor Testing Market are:
- What are the technological innovations in Solid Tumor Testing Market?
- What are the factors driving the growth of the Solid Tumor Testing Market?
- Which technology insight dominated the Solid Tumor Testing Market in 2021?
- How has COVID-19 affected the growth of the Solid Tumor Testing Market?
- What is the growth rate of the Solid Tumor Testing Market during the forecast period?
- What are the trends of the Asia-Pacific region in the Solid Tumor Testing Market?
- Who are the market leaders in Cold Pressed Coconut Oil in the North America region?
- Which deployment mode led the Solid Tumor Testing Market in 2021?
- Who are the key players in the Solid Tumor Testing Market?
- What are the factors restraining the growth of the Solid Tumor Testing Market?
- Which region held the largest market share in Solid Tumor Testing Market?
- What is the growth rate of the North America Solid Tumor Testing Market
- What is key feature of Lung Cancer Screening?
Purchase Report:
https://www.maximizemarketresearch.com/checkout/?method=PayPal&reportId=167421&type=Single%20User
Key Offerings:
- Market Share, Size & Forecast by Revenue | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
- Market Segmentation – Type, Diagnosis, Age Group, End-User and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Maximize Market Research is research firm, has also published the following reports:
Tile Abrasion Testing Market: The tile Abrasion Testing Market size was valued at US$ 4.1 Bn. in 2020 and the total revenue is expected to grow at 5.24% through 2021 to 2027, reaching nearly US$ 5.57 Bn. The growing construction industry, emerging countries, and increasing disposable income in the country are expected to drive the market.
C-reactive Protein Testing Market: The C-reactive Protein Testing Market size was valued at US$ 1.64 Bn. in 2021 and the total revenue is expected to grow at CAGR 1.5% through 2022 to 2029, reaching nearly US$ 1.85 Bn. increasing chronic disease among the population, the demand for this test is increased, which drives market growth.
Sterility Testing Market: The Sterility Testing Market size was valued at US$ 947.25 Mn in 2021 and the total revenue is expected to grow at 12.40% through 2022 to 2029, reaching nearly US$ 2413.21 Mn. The growth of the pharmaceutical industry and biotechnology industry and rapid innovation are driving the growth of the sterility testing market.
Bone Density Testing Market: The Bone Density Testing Market size was valued at US$ 1113.7 Mn in 2021 and the total revenue is expected to grow at 4.5 % through 2021 to 2029, reaching nearly US$ 1583.8 Mn. The increasing population with changing lifestyles like sedentary and increasing urbanization are further boosting the market growth.
Seed Testing Services Market: The seed Testing Services Market size was valued at US$ 863.4 Mn. in 2021 and the total revenue is expected to grow at a CAGR of 6.0% through 2021 to 2029, reaching nearly US$ 1376.2 Mn. The increasing crop production, a rapidly growing agriculture sector, and a rise in demand for seed testing services by producers to improve productivity
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact us for a more detailed view at: sales@maximizemarketresearch.com
